SEPTIN9 and gastric cancer: QMSP has a wide range of clinical applications and is effective in testing aberrant methylation in the early diagnosis of tumors [81], such as methylated Septin9 (mSEPT9) in colorectal cancer or mRNF180 with mSEPT9 in gastric cancer [82].